![Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014 - ScienceDirect Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0952327815300132-gr3.jpg)
Conducting omega-3 clinical trials with cardiovascular outcomes: Proceedings of a workshop held at ISSFAL 2014 - ScienceDirect
![Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis | European Journal of Hospital Pharmacy Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis | European Journal of Hospital Pharmacy](https://ejhp.bmj.com/content/ejhpharm/29/3/134/F1.large.jpg)
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis | European Journal of Hospital Pharmacy
![Omega-3, omega-6 polyunsaturated fatty acids, omega-3/omega-6 polyunsaturated fatty acids ratio and prostate cancer risk Omega-3, omega-6 polyunsaturated fatty acids, omega-3/omega-6 polyunsaturated fatty acids ratio and prostate cancer risk](https://www.researchgate.net/profile/Philippe-Bougnoux/publication/9038824/figure/tbl1/AS:601654902681650@1520457115773/Omega-3-omega-6-polyunsaturated-fatty-acids-omega-3-omega-6-polyunsaturated-fatty_Q640.jpg)
Omega-3, omega-6 polyunsaturated fatty acids, omega-3/omega-6 polyunsaturated fatty acids ratio and prostate cancer risk
![AHA 2020: STRENGTH and OMEMI trials show no cardiovascular benefit derived from omega-3 fatty acid administration - Pharmaceutical Technology AHA 2020: STRENGTH and OMEMI trials show no cardiovascular benefit derived from omega-3 fatty acid administration - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2020/11/shutterstock_526305043-1.jpg)
AHA 2020: STRENGTH and OMEMI trials show no cardiovascular benefit derived from omega-3 fatty acid administration - Pharmaceutical Technology
![Quali sono gli acidi grassi Omega 3 che contrastano lo sviluppo delle malattie cardiovascolari | PIMS Project | Results in brief | H2020 | CORDIS | European Commission Quali sono gli acidi grassi Omega 3 che contrastano lo sviluppo delle malattie cardiovascolari | PIMS Project | Results in brief | H2020 | CORDIS | European Commission](https://cordis.europa.eu/docs/results/images/2020-10/422570.jpg)
Quali sono gli acidi grassi Omega 3 che contrastano lo sviluppo delle malattie cardiovascolari | PIMS Project | Results in brief | H2020 | CORDIS | European Commission
![A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk - Mayo Clinic Proceedings A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk - Mayo Clinic Proceedings](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/78467489-ba7a-4515-b1c3-9b951edfeecd/gr1.jpg)